These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38866784)

  • 1. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.
    Wang X; Zhang J; Liu M; Guo Y; Guo P; Yang X; Shang B; Li M; Tian J; Zhang T; Wang X; Jin R; Zhou J; Gao GF; Liu J
    Signal Transduct Target Ther; 2024 Jun; 9(1):160. PubMed ID: 38866784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A
    Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
    Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
    Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H
    Front Immunol; 2020; 11():579480. PubMed ID: 33250893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide B Cell, CD4
    Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
    J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
    Fernandez SA; Pelaez-Prestel HF; Fiyouzi T; Gomez-Perosanz M; Reiné J; Reche PA
    Front Immunol; 2024; 15():1425374. PubMed ID: 39091504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
    Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW
    PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
    Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
    Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-Cell Receptors Cross-Reactive to Coronaviral Epitopes Homologous to the SPR Peptide.
    Serdyuk YV; Zornikova KV; Dianov DV; Ivanova NO; Davydova VD; Fefelova EI; Nenasheva TA; Sheetikov SA; Bogolyubova AV
    Biochemistry (Mosc); 2024 Sep; 89(9):1631-1642. PubMed ID: 39418521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A2 restricted CD8
    Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
    J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.